Overview
| Product name | Recombinant SARS-COV-2 Nucleocapsid(B.1.1.529/Omicron) Protein |
|---|
| Catalog No. | RP01485LQ |
|---|
| Description | Recombinant SARS-COV-2 Nucleocapsid(B.1.1.529/Omicron) Protein is produced by E. coli expression system. The target protein is expressed with sequence (Ser2-Ala419(P13L, E31del, R32del, S33del, R203K, G204R)) of sars-cov-2 N (B.1.1.529/Omicron) (Accession #QHD43423.2) fused with a 6×His tag at the C-terminus. |
|---|
| Bio-Activity | Measured by its binding ability in a functional ELISA.Immobilized SARS-CoV-2 Envelope at 2 μg/mL (100 μL/well) can bind SARS-COV-2 Nucleocapsid with a linear range of 0.2-65 ng/mL.
|
|---|
| Purity | > 95% by SDS-PAGE. |
|---|
| Endotoxin | <0.1EU/μg |
|---|
| Formulation | Supplied as a 0.22 μm filtered solution in 20mM Tris, 500mM NaCl, 0.1mM EDTA, 10% glycerol, pH8.0. |
|---|
| Species | SARS-COV-2 |
|---|
| Calculated MW | 46.04 kDa |
|---|
Product information
| Synonym | Nucleoprotein |
|---|
| Expression Host | E. coli |
|---|
| Tag | C-His |
|---|
| Gene ID | |
|---|
Usage guide
| Storage | Store at -70℃. This product is stable at ≤ -70℃ for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles. |
|---|
* For research use only. Not for therapeutic or diagnostic purposes.
